EC Number |
Inhibitors |
Structure |
---|
3.4.21.92 | CAANDENYALAA |
- |
|
3.4.21.92 | CAANDENYALAA-NH2 |
- |
|
3.4.21.92 | diisopropylfluorophosphate |
- |
|
3.4.21.92 | fluorosulfonylbenzoyladenosine |
- |
|
3.4.21.92 | NEM |
- |
|
3.4.21.92 | Neohydrin |
- |
|
3.4.21.92 | phosphoarginine |
- |
|
3.4.21.92 | ClpS |
adaptor protein ClpS is inhibitory to ClpC1. the unfolding rate of substrates shows a a nearly three-fold for conditions lacking ClpS relative to conditions with ClpS in excess |
|
3.4.21.92 | 1-(1,1-dioxido-1,2-thiazetidin-2-yl)hexan-1-one |
alkyne-free beta-sultam analogue. Treatment leads to dehydroalanine formation of the active site serine. The reaction proceeds through sulfonylation and subsequent elimination, thereby obliterating the catalytic charge relay system |
|
3.4.21.92 | 1-(4-benzoyl-1,1-dioxido-1,2-thiazetidin-2-yl)ethanone |
alkyne-free beta-sultam analogue. Treatment leads to dehydroalanine formation of the active site serine. The reaction proceeds through sulfonylation and subsequent elimination, thereby obliterating the catalytic charge relay system |
|